A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

Overview of attention for article published in BMC Cancer, October 2017

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

reddit: 1 Redditor

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Facebook Reddit Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Efficacy of Nanoparticle Albumin-Bound Paclitaxel (nab-PTX) Monotherapy Can Be Improved after Treatment with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: Long-Term Follow-Up and Updated Analysis of Two Previous Prospective Clinical Studies

Article in Oncology (January 2024)

Efficacy and safety of utidelone for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer who have failed standard second-line treatment: A phase 2 clinical trial (BG01-1801)

Article in Cancer Pathogenesis and Therapy (October 2023)

Immunotherapy as a later-line option for HER2-altered advanced non-small-cell lung cancer: taxane might be a favorable partner

Article in Future Oncology (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.